Company profile: Insure One
1.1 - Company Overview
Company description
- Provider of at-home fecal immunochemical tests (FIT) for colorectal cancer screening, using a non-invasive brush-based sample collection to detect lower gastrointestinal bleeding without direct stool handling, with a focus on patient compliance and data privacy.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Insure One
Oncimmune
HQ: United Kingdom
Website
- Description: Provider of proprietary autoantibody assay technologies for early cancer detection, offering ImmunoINSIGHTS analytical platform to discover and profile autoantibody biomarkers for disease characterization, patient stratification, and response prediction; biomarker discovery services; customizable targeted panels and arrays for immuno-oncology and autoimmune diseases; and bioinformatics and data science with multiomics integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncimmune company profile →
Imunon
HQ: United States
Website
- Description: Provider of nucleic acid-based immunotherapy and vaccine platforms that harness the body's immune system, including TheraPlas, a nonviral delivery system for anti-cancer nucleic acid therapies initially targeting advanced ovarian cancer; PlaCCine, a multivalent nucleic acid vaccine platform for infectious diseases and cancer; FixPlas, for universal cancer vaccines; and IndiPlas, for personalized neoepitope cancer vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imunon company profile →
Profound Medical
HQ: Canada
Website
- Description: Provider of medical device solutions for MRI-guided ablation in prostate care, offering TULSA-PRO, a transurethral ultrasound ablation system under MRI guidance; Sonalleve, a HIFU therapy platform for non-invasive treatment of uterine fibroids and palliative bone metastases pain; and PRO-Talk, an educational platform with learning resources for physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Profound Medical company profile →
Circio
HQ: Norway
Website
- Description: Provider of active immunotherapy cancer vaccines for post-operation treatments, including TG01, a peptide-based vaccine targeting KRAS/RAS driver mutations in clinical trials for RAS-mutated pancreatic cancer, lung cancer, and multiple myeloma, and circVec, a genetic medicine platform producing multifunctional circular RNA from DNA and viral vectors with enhanced, durable protein expression versus classic mRNA systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circio company profile →
Shorla Oncology
HQ: Ireland
Website
- Description: Provider of innovative oncology drugs focused on women's and pediatric cancers, developing and commercializing life-saving treatments that address unmet needs. Portfolio includes FDA-approved JYLAMVO (oral methotrexate) and TEPYLUTE for breast and ovarian cancer, as well as a Nelarabine Injection; pipeline programs include SH-201 under FDA review and SH-110 in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Shorla Oncology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Insure One
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Insure One
2.2 - Growth funds investing in similar companies to Insure One
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Insure One
4.2 - Public trading comparable groups for Insure One
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →